-
1
-
-
33749319703
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
-
DOI 10.1126/science.1129139
-
Galon J, Costes A, Sanchez-Cabo F, et al,. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-4 (Pubitemid 44498003)
-
(2006)
Science
, vol.313
, Issue.5795
, pp. 1960-1964
-
-
Galon, J.1
Costes, A.2
Sanchez-Cabo, F.3
Kirilovsky, A.4
Mlecnik, B.5
Lagorce-Pages, C.6
Tosolini, M.7
Camus, M.8
Berger, A.9
Wind, P.10
Zinzindohoue, F.11
Bruneval, P.12
Cugnenc, P.-H.13
Trajanoski, Z.14
Fridman, W.-H.15
Pages, F.16
-
2
-
-
0037448353
-
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
-
DOI 10.1056/NEJMoa020177
-
Zhang L, Conejo-Garcia JR, Katsaros D, et al,. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203-13 (Pubitemid 36077915)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.3
, pp. 203-213
-
-
Zhang, L.1
Conejo-Garcia, J.R.2
Katsaros, D.3
Gimotty, P.A.4
Massobrio, M.5
Regnani, G.6
Makrigiannakis, A.7
Gray, H.8
Schlienger, K.9
Liebman, M.N.10
Rubin, S.C.11
Coukos, G.12
-
3
-
-
0027179385
-
T-cell subsets required for intravesical BCG immunotherapy for bladder cancer
-
Ratliff TL, Ritchey JK, Yuan JJ, Andriole GL, Catalona WJ,. T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J Urol 1993; 150: 1018-23 (Pubitemid 23241327)
-
(1993)
Journal of Urology
, vol.150
, Issue.3
, pp. 1018-1023
-
-
Ratliff, T.L.1
Ritchey, J.K.2
Yuan, J.J.J.3
Andriole, G.L.4
Catalona, W.J.5
-
4
-
-
33947259319
-
Immunosuppressive strategies that are mediated by tumor cells
-
DOI 10.1146/annurev.immunol.25.022106.141609
-
Rabinovich GA, Gabrilovich D, Sotomayor EM,. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25: 267-96 (Pubitemid 46697910)
-
(2007)
Annual Review of Immunology
, vol.25
, pp. 267-296
-
-
Rabinovich, G.A.1
Gabrilovich, D.2
Sotomayor, E.M.3
-
5
-
-
33646804507
-
Mechanisms of Immune Evasion by Tumors
-
DOI 10.1016/S0065-2776(06)90002-9, PII S0065277606900029
-
Drake CG, Jaffee E, Pardoll DM,. Mechanisms of immune evasion by tumors. Adv Immunol 2006; 90: 51-81 (Pubitemid 43765799)
-
(2006)
Advances in Immunology
, vol.90
, pp. 51-81
-
-
Drake, C.G.1
Jaffee, E.2
Pardoll, D.M.3
-
6
-
-
0029150110
-
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
-
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M,. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64
-
(1995)
J Immunol
, vol.155
, pp. 1151-1164
-
-
Sakaguchi, S.1
Sakaguchi, N.2
Asano, M.3
Itoh, M.4
Toda, M.5
-
7
-
-
45449095936
-
FOXP3 promoter demethylation reveals the committed Treg population in humans
-
Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O,. FOXP3 promoter demethylation reveals the committed Treg population in humans. Plos ONE 2008; 3: E1612
-
(2008)
Plos ONE
, vol.3
-
-
Janson, P.C.1
Winerdal, M.E.2
Marits, P.3
Thorn, M.4
Ohlsson, R.5
Winqvist, O.6
-
8
-
-
0346969978
-
- T cells
-
DOI 10.1172/JCI200319441
-
- T cells. J Clin Invest 2003; 112: 1437-43 (Pubitemid 38057697)
-
(2003)
Journal of Clinical Investigation
, vol.112
, Issue.9
, pp. 1437-1443
-
-
Walker, M.R.1
Kasprowicz, D.J.2
Gersuk, V.H.3
Benard, A.4
Van Landeghen, M.5
Buckner, J.H.6
Ziegler, S.F.7
-
10
-
-
33644844341
-
Molecular mechanisms underlying FOXP3 induction in human T cells
-
Mantel PY, Ouaked N, Ruckert B, et al,. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006; 176: 3593-602 (Pubitemid 43364007)
-
(2006)
Journal of Immunology
, vol.176
, Issue.6
, pp. 3593-3602
-
-
Mantel, P.-Y.1
Ouaked, N.2
Ruckert, B.3
Karagiannidis, C.4
Welz, R.5
Blaser, K.6
Schmidt-Weber, C.B.7
-
11
-
-
0037312480
-
Increase of regulatory T cells in the peripheral blood of cancer patients
-
Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B,. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9: 606-12 (Pubitemid 36182591)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.2
, pp. 606-612
-
-
Wolf, A.M.1
Wolf, D.2
Steurer, M.3
Gastl, G.4
Gunsilius, E.5
Grubeck-Loebenstein, B.6
-
12
-
-
33845311502
-
Human Bladder Carcinoma is Dominated by T-Regulatory Cells and Th1 Inhibitory Cytokines
-
DOI 10.1016/j.juro.2006.08.078, PII S0022534706022038
-
Loskog A, Ninalga C, Paul-Wetterberg G, de la Torre M, Malmstrom PU, Totterman TH,. Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines. J Urol 2007; 177: 353-8 (Pubitemid 44879486)
-
(2007)
Journal of Urology
, vol.177
, Issue.1
, pp. 353-358
-
-
Loskog, A.1
Ninalga, C.2
Paul-Wetterberg, G.3
De La Torre, M.4
Malmstrom, P.-U.5
Totterman, T.H.6
-
13
-
-
33845933229
-
CD4 regulatory T cells in human cancer pathogenesis
-
DOI 10.1007/s00262-006-0194-y
-
Knutson KL, Disis ML, Salazar LG,. CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 2007; 56: 271-85 (Pubitemid 46035899)
-
(2007)
Cancer Immunology, Immunotherapy
, vol.56
, Issue.3
, pp. 271-285
-
-
Knutson, K.L.1
Disis, M.L.2
Salazar, L.G.3
-
14
-
-
1642497640
-
+ Regulatory T Cells and Their Ligands: Implications for Immunotherapy
-
DOI 10.1016/S1074-7613(03)00359-5
-
+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004; 20: 107-18 (Pubitemid 38134298)
-
(2004)
Immunity
, vol.20
, Issue.1
, pp. 107-118
-
-
Wang, H.Y.1
Lee, D.A.2
Peng, G.3
Guo, Z.4
Li, Y.5
Kiniwa, Y.6
Shevach, E.M.7
Wang, R.-F.8
-
15
-
-
33744457276
-
high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers
-
DOI 10.1007/s00262-005-0092-8
-
Kono K, Kawaida H, Takahashi A, et al,. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 2006; 55: 1064-71 (Pubitemid 43800721)
-
(2006)
Cancer Immunology, Immunotherapy
, vol.55
, Issue.9
, pp. 1064-1071
-
-
Kono, K.1
Kawaida, H.2
Takahashi, A.3
Sugai, H.4
Mimura, K.5
Miyagawa, N.6
Omata, H.7
Fujii, H.8
-
16
-
-
13944260193
-
high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer
-
DOI 10.1016/j.jss.2004.10.004
-
+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res 2005; 124: 151-7 (Pubitemid 40269816)
-
(2005)
Journal of Surgical Research
, vol.124
, Issue.1
, pp. 151-157
-
-
Kawaida, H.1
Kono, K.2
Takahashi, A.3
Sugai, H.4
Mimura, K.5
Miyagawa, N.6
Omata, H.7
Ooi, A.8
Fujii, H.9
-
17
-
-
30144436959
-
Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast
-
DOI 10.1016/j.imlet.2005.09.006, PII S0165247805002804
-
Leong PP, Mohammad R, Ibrahim N, et al,. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Immunol Lett 2006; 102: 229-36 (Pubitemid 43053092)
-
(2006)
Immunology Letters
, vol.102
, Issue.2
, pp. 229-236
-
-
Leong, P.P.1
Mohammad, R.2
Ibrahim, N.3
Ithnin, H.4
Abdullah, M.5
Davis, W.C.6
Seow, H.F.7
-
18
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
DOI 10.1038/nm1093
-
Curiel TJ, Coukos G, Zou L, et al,. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-9 (Pubitemid 39273735)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
19
-
-
31544455880
-
+ T-cell subpopulations in head and neck cancers
-
DOI 10.1158/1078-0432.CCR-05-1886
-
+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006; 12: 465-72 (Pubitemid 43166137)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.2
, pp. 465-472
-
-
Badoual, C.1
Hans, S.2
Rodriguez, J.3
Peyrard, S.4
Klein, C.5
Agueznay, N.E.H.6
Mosseri, V.7
Laccourreye, O.8
Bruneval, P.9
Fridman, W.H.10
Brasnu, D.F.11
Tartour, E.12
-
20
-
-
58249089749
-
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer
-
Salama P, Phillips M, Grieu F, et al,. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009; 27: 186-92
-
(2009)
J Clin Oncol
, vol.27
, pp. 186-192
-
-
Salama, P.1
Phillips, M.2
Grieu, F.3
-
21
-
-
34548590227
-
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer
-
DOI 10.1158/0008-5472.CAN-06-3304
-
Hinz S, Pagerols-Raluy L, Oberg HH, et al,. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 2007; 67: 8344-50 (Pubitemid 47395173)
-
(2007)
Cancer Research
, vol.67
, Issue.17
, pp. 8344-8350
-
-
Hinz, S.1
Pagerols-Raluy, L.2
Oberg, H.-H.3
Ammerpohl, O.4
Grussel, S.5
Sipos, B.6
Grutzmann, R.7
Pilarsky, C.8
Ungefroren, H.9
Saeger, H.-D.10
Kloppel, G.11
Kabelitz, D.12
Kalthoff, H.13
-
23
-
-
64649088372
-
FOXP3 expression and overall survival in breast cancer
-
Merlo A, Casalini P, Carcangiu ML, et al,. FOXP3 expression and overall survival in breast cancer. J Clin Oncol 2009; 27: 1746-52
-
(2009)
J Clin Oncol
, vol.27
, pp. 1746-1752
-
-
Merlo, A.1
Casalini, P.2
Carcangiu, M.L.3
-
24
-
-
0037470276
-
Methods for categorizing a prognostic variable in a multivariable setting
-
DOI 10.1002/sim.1333
-
Mazumdar M, Smith A, Bacik J,. Methods for categorizing a prognostic variable in a multivariable setting. Stat Med 2003; 22: 559-71 (Pubitemid 36204178)
-
(2003)
Statistics in Medicine
, vol.22
, Issue.4
, pp. 559-571
-
-
Mazumdar, M.1
Smith, A.2
Bacik, J.3
-
25
-
-
0035655979
-
7 phenotype and E-cadherin in normal human urothelium and bladder carcinomas
-
DOI 10.1046/j.1365-2249.2001.01652.x
-
Cresswell J, Robertson H, Neal DE, Griffiths TR, Kirby JA,. Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas. Clin Exp Immunol 2001; 126: 397-402 (Pubitemid 34008709)
-
(2001)
Clinical and Experimental Immunology
, vol.126
, Issue.3
, pp. 397-402
-
-
Cresswell, J.1
Robertson, H.2
Neal, D.E.3
Griffiths, T.R.L.4
Kirby, J.A.5
-
26
-
-
0032529466
-
+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
-
+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 3491-4 (Pubitemid 28376536)
-
(1998)
Cancer Research
, vol.58
, Issue.16
, pp. 3491-3494
-
-
Naito, Y.1
Saito, K.2
Shiiba, K.3
Ohuchi, A.4
Saigenji, K.5
Nagura, H.6
Ohtani, H.7
-
27
-
-
0014887939
-
The concept of immunological surveillance
-
Burnet FM,. The concept of immunological surveillance. Prog Exp Tumor Res 1970; 13: 1-27
-
(1970)
Prog Exp Tumor Res
, vol.13
, pp. 1-27
-
-
Burnet, F.M.1
-
29
-
-
34247271873
-
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
-
DOI 10.1073/pnas.0611618104
-
Sharma P, Shen Y, Wen S, et al,. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci USA 2007; 104: 3967-72 (Pubitemid 47181562)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.10
, pp. 3967-3972
-
-
Sharma, P.1
Shen, Y.2
Wen, S.3
Yamada, S.4
Jungbluth, A.A.5
Gnjatic, S.6
Bajorin, D.F.7
Reuter, V.E.8
Herr, H.9
Old, L.J.10
Sato, E.11
-
30
-
-
0027420188
-
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer
-
Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R,. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer 1992; 29A: 69-75
-
(1992)
Eur J Cancer
, vol.29 A
, pp. 69-75
-
-
Lipponen, P.K.1
Eskelinen, M.J.2
Jauhiainen, K.3
Harju, E.4
Terho, R.5
-
31
-
-
34247261531
-
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
-
DOI 10.1200/JCO.2006.05.9584
-
Bates GJ, Fox SB, Han C, et al,. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006; 24: 5373-80 (Pubitemid 46623168)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.34
, pp. 5373-5380
-
-
Bates, G.J.1
Fox, S.B.2
Han, C.3
Leek, R.D.4
Garcia, J.F.5
Harris, A.L.6
Banham, A.H.7
-
32
-
-
78651098988
-
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
-
Ladoire S, Arnould L, Mignot G, et al,. Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 2011; 125: 65-72
-
(2011)
Breast Cancer Res Treat
, vol.125
, pp. 65-72
-
-
Ladoire, S.1
Arnould, L.2
Mignot, G.3
-
33
-
-
34447136106
-
Cancer vaccines: Moving beyond current paradigms
-
DOI 10.1158/1078-0432.CCR-07-0588
-
Schlom J, Arlen PM, Gulley JL,. Cancer vaccines: moving beyond current paradigms. Clin Cancer Res 2007; 13: 3776-82 (Pubitemid 47037581)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.13
, pp. 3776-3782
-
-
Schlom, J.1
Arlen, P.M.2
Gulley, J.L.3
-
34
-
-
70849108700
-
Three distinct domains contribute to nuclear transport of murine Foxp3
-
Hancock WW, Ozkaynak E,. Three distinct domains contribute to nuclear transport of murine Foxp3. Plos One 2009; 4: E7890
-
(2009)
Plos One
, vol.4
-
-
Hancock, W.W.1
Ozkaynak, E.2
-
35
-
-
29044444695
-
Detection of immune responses against urinary bladder cancer in sentinel lymph nodes
-
DOI 10.1016/j.eururo.2005.09.010, PII S0302283805005804
-
Marits P, Karlsson M, Sherif A, Garske U, Thorn M, Winqvist O,. Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol 2006; 49: 59-70 (Pubitemid 41789957)
-
(2006)
European Urology
, vol.49
, Issue.1
, pp. 59-70
-
-
Marits, P.1
Karlsson, M.2
Sherif, A.3
Garske, U.4
Thorn, M.5
Winqvist, O.6
|